首页 > 市场调查报告书 > 製药

消化器

市场调查报告书

商品编码

1392116

肛裂治疗市场：依治疗类型、给药途径、配销通路及地区

Anal Fissure Treatment Market, By Treatment Type, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2023年11月22日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2023年全球肛裂治疗市场规模为10.393亿美元，预计2030年将达14.919亿美元，2023年至2030年复合年增长率为5.3%。

报告范围		报告详情
基准年	2022年	2023年市场规模	10.393 亿美元
实绩资料	2018-2021	预测期	2023-2030
预测期复合年增长率	5.30%	2030年市场规模预测	14.919 亿美元

图 1. 2023 年肛裂治疗的全球市场占有率（按地区划分）

肛裂是一种常见的疾病，影响着世界各地的许多人。肛门黏膜出现小撕裂或割伤，引起不适、疼痛，有时还会在排便时出血。儘管肛裂可能会自行癒合，但通常需要治疗来缓解症状并促进癒合。

大多数肛裂会在几週内自行癒合，但如果不癒合可能会出现併发症。这些被称为慢性肛裂。肛裂非但没有癒合，反而重复恶性循环，疤痕持续存在。

肛裂的症状包括排便时疼痛、排便后疼痛持续数小时、排便后大便或卫生纸上有鲜红色血、肛门周围皮肤可见裂纹以及肛裂周围皮肤。这可能包括小肿块或皮赘。

由于全球肛裂盛行率不断上升，全球肛裂治疗市场正在显着成长。久坐的生活方式、不良的饮食习惯和人口高龄化等因素导致肛裂发生率增加。人们对各种治疗方案的可用性的认识不断提高，以及对微创手术的需求不断增加，进一步推动了市场的成长。

市场动态：

全球肛裂盛行率的增加和市场参与企业不断推出的产品预计将在预测期内推动市场成长。例如，根据临床医学2022年9月15日发布的资料，新墨西哥州一般人群肛裂的年发生率为0.11%。

本研究的主要特点

本研究对全球肛裂治疗市场进行了全面分析，包括以 2022 年为基准年的 2023 年至 2030 年预测期内的市场规模和复合年增长率。
该报告阐明了各个细分市场的潜在商机，并为该市场提供了一系列有吸引力的投资提案。
它提供了有关市场驱动因素、抑制因素因素、机会、新产品发布和核准、市场趋势和驱动因素、区域前景、主要企业采取的竞争策略等的重要考察。
全球肛裂治疗市场主要企业的简介，重点介绍公司背景、产品系列、财务实绩、策略等。
这项研究的主要企业包括Abbie、诺华、Teva Pharmaceuticals、Troikaa、RDD Pharma, Ltd、Kyowa Kirin Co., Ltd.、Cipla Inc.、Ipsen Pharma、Sanofi、Boehringer Ingelheim International GmbH、Bliss GVS、SRS Life Sciences 、健康类包括Life Pharma Private Limited、Geri-Care Pharmaceuticals Corp.等。
该报告的见解使公司行销人员和负责人能够就产品发布、市场扩张和行销策略做出资讯的决策。
全球肛裂治疗市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过用于分析全球肛裂治疗市场的各种策略矩阵做出资讯的决策。

介绍
北美洲
美国
加拿大
欧洲
英国
德国
法国
义大利
西班牙
俄罗斯
欧洲其他地区
亚太地区
中国
日本
印度
澳洲
韩国
东南亚国协
其他亚太地区
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲
中东
海湾合作委员会国家
以色列
其他中东地区
非洲
南非
北非
中部非洲

第9章竞争形势

Abbvie
Novartis AG
Teva Pharmaceuticals
Troikaa
RDD Pharma, Ltd
Kyowa Kirin Co., Ltd
Cipla Inc.
Ipsen Pharma
Sanofi
Boehringer Ingelheim International GmbH
Bliss GVS
SRS Life Sciences
Healthy Life Pharma Private Limited
Geri-Care Pharmaceuticals Corp

第10章

调查方法
关于出版商

简介目录

Product Code: CMI6358

Global Anal Fissure Treatment Market is estimated to be valued at US$ 1,039.3 Mn in 2023, and is expected to reach US$ 1,491.9 Mn by 2030, exhibiting a compound annual growth rate (CAGR) of 5.3% from 2023 to 2030.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 1,039.3 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	5.30%	2030 Value Projection:	US$ 1,491.9 Mn

Figure 1. Global Anal Fissure Treatment Market Share (%), By Region, 2023

Anal fissure is a common medical condition that affects a significant number of individuals worldwide. It refers to a small tear or cut in the lining of the anus, resulting in discomfort, pain, and sometimes bleeding during bowel movements. While anal fissures can heal on their own, it often require treatment to alleviate symptoms and promote healing.

Many anal fissures heal by themselves in a few weeks, but complications can develop when they don't. These are called chronic anal fissures. Instead of healing, they continue to reinforce themselves in a vicious cycle, leaving a persistent wound.

Symptoms of anal fissure includes; Pain during bowel movements, Pain after bowel movements that can last up to several hours, Bright red blood on the stool or toilet paper after a bowel movement, a visible crack in the skin around the anus, a small lump or skin tag on the skin near the anal fissure

Global anal fissure treatment market is witnessing significant growth due to increasing prevalence of anal fissures globally. Factors such as sedentary lifestyles, poor dietary habits, and rising aging population contribute to growing incidence of anal fissures. Rising awareness about the availability of various treatment options and increasing demand for minimally invasive procedures are further driving the market growth.

Market Dynamics:

Increasing prevalence of anal fissure globally and increasing product launches by the market players are expected to aid drive the market growth over the forecast period. For instance, on September 15, 2022, according to the data published by the Clinical Medicine, annual incidence of anal fissures in the general population is 0.11% in New Mexico.

Key Features of the Study:

This study provides a comprehensive analysis of the global anal fissure treatment market, including market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period of 2023-2030, with 2022 as the base year
The report elucidates potential revenue opportunities across different segments and offers attractive investment proposition matrices for this market
It provides key insights into market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
The profiles of key players in the global anal fissure treatment market are included, highlighting their company background, product portfolio, financial performance, and strategies
Key companies covered in this study include Abvie, Novartis AG, Teva Pharmaceuticals, Troikaa, RDD Pharma, Ltd, Kyowa Kirin Co., Ltd, Cipla Inc., Ipsen Pharma, Sanofi, Boehringer Ingelheim International GmbH, Bliss GVS, SRS Life Sciences, Healthy Life Pharma Private Limited, and Geri-Care Pharmaceuticals Corp
The insights from this report enable marketers and management authorities of companies to make informed decisions regarding product launches, market expansion, and marketing tactics
Global anal fissure treatment market report caters to various stakeholders in the industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders can make informed decisions through different strategy matrices used in analyzing the global anal fissure treatment market

Anal Fissure Treatment Market Detailed Segmentation:

By Treatment Type
- Laxatives
- Topical Nitrates
- Calcium Channel Blockers
- Stool Softeners
- Surgery
- Others
By Route of Administration
- Oral
- Topical
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Top companies in Global Anal Fissure Treatment Market
- Abvie
- Novartis AG
- Teva Pharmaceuticals
- Troikaa
- RDD Pharma, Ltd
- Kyowa Kirin Co., Ltd
- Cipla Inc.
- Ipsen Pharma
- Sanofi
- Boehringer Ingelheim International GmbH.
- Bliss GVS
- SRS Life Sciences
- Healthy Life Pharma Private Limited
- Geri-Care Pharmaceuticals Corp.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Anal Fissure Treatment Market, By Treatment Type
- Anal Fissure Treatment Market, By Route of Administration
- Anal Fissure Treatment Market, By Distribution Channel
- Anal Fissure Treatment Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing Prevalence of Anal Fissures
Rising Awareness and Removing Social Stigma
- Restraints
Social Taboo Inhibiting Treatment Seeking
Product Recall
- Opportunities
Huge Scope in Emerging Economies
Growing Demand for Minimally Invasive Procedures
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Anal Fissure Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Anal Fissure Treatment Market, By Treatment Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Laxatives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Topical Nitrates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Calcium Channel Blockers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Stool Softeners
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

6. Global Anal Fissure Treatment Market, By Route of Administration, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

7. Global Anal Fissure Treatment Market, By Distribution Channel, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

8. Global Anal Fissure Treatment Market, By Region, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
U.K.
Germany
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
China
Japan
India
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Mn)
South Africa
North Africa
Central Africa

9. Competitive Landscape

Abbvie
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
Teva Pharmaceuticals
Troikaa
RDD Pharma, Ltd
Kyowa Kirin Co., Ltd
Cipla Inc.
Ipsen Pharma
Sanofi
Boehringer Ingelheim International GmbH
Bliss GVS
SRS Life Sciences
Healthy Life Pharma Private Limited
Geri-Care Pharmaceuticals Corp
Analyst Views

10. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

肛裂治疗市场：依治疗类型、给药途径、配销通路及地区